Independent Director Mr. Ashok Bhandari passes away

Management Changes View source PDF Explain this filing

JGCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.6%Reaction day

₹546.00

prior close

₹542.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.0% vs market

Commodity Chemicals peers, median of 53sector-0.2%-1.5% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.5 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.2

15m

-0.1

30m

-0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.6+0.4-2.0-0.2-1.5

Next day

+1.4+0.4+1.0-0.6+2.0

+13.4+0.3+13.1-0.4+13.9

+13.9+0.2+13.7-0.9+14.8

+10.4+0.5+9.9-1.4+11.8

+12.3+0.7+11.6-2.1+14.4

+10.2+0.9+9.3-1.7+11.9

15d

+7.5+1.6+5.8-1.9+9.3

+7.7+2.4+5.3+0.3+7.4

+22.0+1.1+20.8-0.9+22.9

—————

UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Ashok Bhandari, an Independent Director of J.G. Chemicals since June 30, 2022, passed away on August 3, 2026. He served on the Audit Committee, Nomination and Remuneration Committee, CSR Committee, Risk Management Committee, and Committee of Board of Directors. His committee memberships ceased with immediate effect. The company will need to appoint a replacement to maintain regulatory compliance on board composition and committees.

Likely market impact

Board will need to fill the independent director vacancy and committee seats to comply with SEBI rules. Watch for update on new appointment. No operational impact expected.